How to Test for Insulin Resistance in the UK

How to test for insulin resistance is an important question for anyone concerned about their metabolic health, particularly those with risk factors such as excess abdominal weight, a family history of type 2 diabetes, or polycystic ovary syndrome. Insulin resistance often develops without obvious symptoms, making formal testing essential for early detection. This article explains the blood tests used in UK clinical practice, what your results mean, whether home testing has a role, and what steps to take if your results suggest a problem.

What is insulin resistance and why does it matter?

Insulin resistance occurs when cells respond poorly to insulin, forcing the pancreas to produce more, which can eventually lead to type 2 diabetes, metabolic syndrome, and cardiovascular disease if unaddressed.

Insulin resistance is a condition in which the body's cells respond less effectively to insulin, the hormone that regulates blood glucose, meaning the pancreas must produce progressively more insulin to maintain normal blood sugar levels. Over time, this compensatory mechanism can fail, leading to persistently elevated blood glucose and, eventually, type 2 diabetes. Insulin resistance is also closely linked to a cluster of metabolic abnormalities collectively known as metabolic syndrome, which includes raised blood pressure, abnormal blood lipids, and excess abdominal fat.^[1][2]

The condition is more common than many people realise. It often develops silently, without obvious symptoms, which is why formal testing is important for those at higher risk. Risk factors recognised in NHS and NICE guidance on preventing type 2 diabetes include:

• Excess body weight, particularly central (abdominal) obesity

• Physical inactivity

• A family history of type 2 diabetes

• Polycystic ovary syndrome (PCOS)

• Certain ethnic backgrounds, including South Asian, Black African, and Black Caribbean heritage

• A history of gestational diabetes

Understanding why insulin resistance matters goes beyond diabetes prevention. Chronic insulin resistance is associated with metabolic dysfunction-associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease or NAFLD), cardiovascular disease, and hormonal conditions such as PCOS.^[6][7] Identifying it early gives individuals and clinicians the opportunity to intervene with lifestyle changes or, where appropriate, medication before more serious complications develop. Because the condition progresses gradually, even modest improvements in diet, physical activity, and body weight can meaningfully reduce insulin resistance and its downstream risks.

How do doctors test for insulin resistance in the UK?

UK doctors primarily use HbA1c and fasting plasma glucose as first-line tests; OGTT is used when HbA1c is inconclusive or unreliable, and HOMA-IR is reserved for specialist settings.

Doctors in the UK test for insulin resistance primarily through blood tests that assess glucose regulation and, in some clinical settings, insulin levels, though there is no single universally agreed diagnostic test for insulin resistance in routine NHS practice. The most commonly used assessments are outlined below.

Fasting plasma glucose and HbA1c are the standard first-line investigations recommended by NICE for identifying impaired glucose regulation and type 2 diabetes. HbA1c reflects average blood glucose over the preceding two to three months and does not require fasting. A result of 42 to 47 mmol/mol indicates non-diabetic hyperglycaemia (sometimes called prediabetes), while 48 mmol/mol or above is diagnostic of type 2 diabetes.^[3][9] It is important to note that HbA1c can be unreliable in certain circumstances, including in people with haemoglobin variants or haemoglobinopathies (such as sickle cell trait or thalassaemia), iron deficiency or haemolytic anaemia, advanced chronic kidney disease, HIV infection, and during or shortly after pregnancy. In these situations, fasting plasma glucose or an oral glucose tolerance test is preferred. HbA1c is also not used to diagnose gestational diabetes.

Random plasma glucose may be used when a patient presents with classic symptoms of hyperglycaemia (see below). A result of 11.1 mmol/L or above in a symptomatic person is diagnostic of diabetes without the need for a fasting test.

The oral glucose tolerance test (OGTT) involves measuring blood glucose before and two hours after drinking a standard 75 g glucose solution. It is used when HbA1c results are inconclusive, when HbA1c is unreliable, or in specific clinical contexts. Under NICE guidance on diabetes in pregnancy, OGTT is offered to women with identified risk factors for gestational diabetes rather than universally.^[10][11] OGTT thresholds (WHO/UK-adopted criteria) are: a two-hour glucose of 7.8 to 11.0 mmol/L indicates impaired glucose tolerance (IGT); 11.1 mmol/L or above is diagnostic of diabetes. Women who have had gestational diabetes are usually offered an OGTT at 6 to 13 weeks postpartum to check for persistent glucose abnormalities.^[10][11]

Fasting insulin and the HOMA-IR score (Homeostatic Model Assessment of Insulin Resistance) are used in some specialist and research settings. HOMA-IR is calculated from fasting glucose and fasting insulin values and provides an estimate of insulin resistance. However, fasting insulin assays are not standardised across laboratories, cut-off values vary between assays, and this test is not routinely available on the NHS. Results must be interpreted by a clinician familiar with the specific assay and laboratory reference ranges used.

Lipid profiles and liver function tests may also be requested, as dyslipidaemia (particularly raised triglycerides and low HDL cholesterol) and raised liver enzymes can accompany insulin resistance.

In UK primary care, validated risk-assessment tools such as QDiabetes are used to identify individuals at high risk who should be prioritised for formal testing. Your GP is the appropriate first point of contact if you are concerned about your risk. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations, with prescriber review and pharmacist support, for those seeking further guidance on metabolic health.

Can you check for insulin resistance at home?

No validated home test directly measures insulin resistance, but accredited private HbA1c, fasting glucose, and HOMA-IR panels, alongside waist circumference measurement, can provide useful preliminary information.

There is no validated, clinically accurate home test that directly measures insulin resistance, but several at-home and private laboratory tests can provide useful preliminary information that you should then discuss with a healthcare professional. It is important to understand the limitations of these options before drawing conclusions from them.

At-home finger-prick blood tests for HbA1c and fasting glucose are available from a number of accredited private laboratories and some pharmacies. These can indicate whether your blood glucose regulation falls within a normal, borderline, or elevated range. However, the accuracy of self-collected samples can vary, and results should always be interpreted alongside clinical context. Where possible, choose a laboratory accredited by UKAS to ISO 15189 standard, and ensure that any home sampling kit carries CE or UKCA marking, as these provide assurance of quality and analytical reliability.

Private blood test panels that include fasting insulin, fasting glucose, and calculated HOMA-IR are available through accredited UK laboratories without a GP referral. These can give a broader picture of metabolic health, including lipid levels and liver markers. As noted above, fasting insulin assays are not standardised, so a clinician should always review the results in the context of the laboratory's own reference ranges.

Waist circumference measurement is a simple, free, and evidence-supported proxy for central adiposity, which is strongly associated with insulin resistance. NICE guidance on obesity and weight management highlights waist circumference as a useful clinical indicator. A waist measurement above 94 cm in men or above 80 cm in women is associated with increased metabolic risk; lower thresholds apply for South Asian individuals, where a cut-off of 90 cm is commonly used for men and 80 cm for women, reflecting higher metabolic risk at a given waist size.^[12][13] To measure correctly, place the tape midway between the lower rib and the top of the hip bone (iliac crest), breathe out normally, and take the reading without pulling the tape tight. The NHS website provides further guidance on waist measurement technique.

Home testing can be a useful starting point for awareness, but it should never replace a formal clinical assessment. If any home test result falls outside the normal range, or if you have multiple risk factors for insulin resistance, contact your GP for a comprehensive evaluation rather than acting on home results alone.

What do your test results actually mean?

A fasting plasma glucose of 6.1 to 6.9 mmol/L indicates impaired fasting glucose, and an HbA1c of 42 to 47 mmol/mol indicates prediabetes; results must be interpreted alongside symptoms and risk factors.

Understanding your test results requires knowing the reference ranges used in UK clinical practice and recognising that no single number tells the whole story. Results should always be interpreted in the context of your symptoms, risk factors, and other investigations.

HbA1c interpretation (NICE thresholds):

• Below 42 mmol/mol: normal

• 42 to 47 mmol/mol: non-diabetic hyperglycaemia (prediabetes), indicating increased risk

• 48 mmol/mol or above: type 2 diabetes (requires confirmation with a repeat test if asymptomatic)

Remember that HbA1c may be unreliable in certain clinical situations (including haemoglobin variants, anaemia, advanced kidney disease, and pregnancy); in these cases, fasting plasma glucose or OGTT results take precedence.

Fasting plasma glucose:

• Below 6.1 mmol/L: normal

• 6.1 to 6.9 mmol/L: impaired fasting glucose

• 7.0 mmol/L or above: consistent with diabetes

OGTT two-hour glucose (WHO/UK-adopted criteria):

• Below 7.8 mmol/L: normal glucose tolerance

• 7.8 to 11.0 mmol/L: impaired glucose tolerance (IGT)

• 11.1 mmol/L or above: consistent with diabetes

HOMA-IR does not have a universally agreed cut-off in UK clinical guidelines, and reference ranges vary between laboratories and assays. A higher HOMA-IR score suggests greater insulin resistance, but the result must be interpreted by a clinician familiar with the assay used.

Lipid results associated with insulin resistance typically show raised triglycerides and low HDL cholesterol, a pattern sometimes described as atherogenic dyslipidaemia.

A result in the normal range does not entirely exclude insulin resistance, particularly if measured at an early stage. Conversely, a borderline result does not mean diabetes is inevitable. Many people with non-diabetic hyperglycaemia return to normal glucose regulation through sustained lifestyle changes. UK practice generally recommends repeating HbA1c or fasting plasma glucose every 6 to 12 months in people with non-diabetic hyperglycaemia, to monitor for progression or improvement.^[3]

If your results are borderline or abnormal, your GP or practice nurse can explain what they mean for you specifically and discuss the most appropriate next steps. In England, this may include referral to the NHS Diabetes Prevention Programme (NHS DPP). Access and self-referral options vary by Integrated Care Board (ICB) area. Equivalent programmes are available in Scotland (Diabetes Prevention Programme Scotland), Wales (Diabetes Prevention Programme Wales), and Northern Ireland; your GP can advise on local referral routes.

What should you do if your results suggest insulin resistance?

Discuss results with your GP promptly, as insulin resistance is often reversible through lifestyle changes; referral to the NHS Diabetes Prevention Programme may be appropriate for those with non-diabetic hyperglycaemia.

If your test results suggest insulin resistance or non-diabetic hyperglycaemia, the most important first step is to discuss them with your GP, who can confirm the findings, rule out other causes, and help you access appropriate support. Acting promptly is worthwhile because insulin resistance is often reversible, particularly in its earlier stages.

Lifestyle changes remain the most evidence-based intervention. NICE guidance on preventing type 2 diabetes and the UK Chief Medical Officers' Physical Activity Guidelines emphasise:

• Dietary modification: reducing refined carbohydrates and added sugars, increasing fibre, and following a balanced diet

• Regular physical activity: at least 150 minutes of moderate-intensity activity per week, in line with UK Chief Medical Officers' guidelines

• Weight management: even a modest reduction in body weight (around 5 to 10 per cent) can significantly improve insulin sensitivity, as supported by UK evidence on diabetes prevention^[3][18]

• Reducing sedentary behaviour and improving sleep quality, both of which influence glucose metabolism

The NHS Diabetes Prevention Programme (NHS DPP) is a free, evidence-based behavioural programme available to adults in England with non-diabetic hyperglycaemia. Your GP can refer you, or you may be able to self-refer depending on your local Integrated Care Board (ICB). Eligibility criteria and self-referral availability vary by area. Equivalent programmes exist in Scotland, Wales, and Northern Ireland; your GP can advise on local access.

Medication is not routinely prescribed solely for insulin resistance in the absence of type 2 diabetes. However, your GP may consider metformin in certain circumstances for people at high risk, where lifestyle changes have not been sufficient. Use of metformin for diabetes prevention in this context is off-label in the UK and should follow NICE guidance on type 2 diabetes prevention in people at high risk.^[3][4]

Recognising symptoms that need prompt attention. Classic symptoms of high blood glucose include increased thirst, passing urine more frequently than usual, unexplained weight loss, blurred vision, and recurrent infections. If you develop these symptoms, contact your GP promptly rather than waiting for a routine appointment. If you feel acutely unwell with symptoms such as severe vomiting, confusion, drowsiness, or signs of severe dehydration, seek urgent medical attention by calling 999 or going to your nearest A&E department. For non-urgent concerns or advice outside GP hours, NHS 111 can help.

Early intervention offers the best opportunity to prevent progression to type 2 diabetes and its associated complications.

Scientific References

1. Metabolic syndrome.
2. Cardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review.
3. Type 2 diabetes: prevention in people at high risk (PH38) – recommendations.
4. Type 2 diabetes: prevention in people at high risk (PH38) – guideline overview.
5. Health matters: preventing Type 2 Diabetes.
6. Metabolic dysfunction-associated steatotic liver disease (NG49).
7. Prediction of metabolic dysfunction-associated steatotic liver disease among patients with type 2 diabetes mellitus using liver fat indices in a resource-limited clinical setting.
8. Key Hepatokines Linking MASLD and Type 2 Diabetes: From Pathophysiological Mechanisms to Therapeutic Modulation.
9. Diabetes | Treatment summaries.
10. Diabetes in pregnancy: management from preconception to the postnatal period (NG3) – recommendations.
11. Diabetes in pregnancy: management from preconception to the postnatal period (NG3) – guideline overview.
12. Overweight and obesity management (NG246) – Identifying and assessing overweight, obesity and central adiposity.
13. Appendix A1: Summary of evidence from surveillance (NG246).
14. Preventing the progression of pre-diabetes to type 2 diabetes – evidence review (PH38).
15. UK Chief Medical Officers' physical activity guidelines.
16. Physical activity guidelines: UK Chief Medical Officers' report.
17. Physical activity guidelines for adults aged 19 to 64.
18. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin.

Frequently Asked Questions